Skip to main content
Clinical Trials/ISRCTN29863753
ISRCTN29863753
Completed
Not Applicable

Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light: a double-blind randomised controlled trial

etherlands Institute for Neuroscience (Netherlands)0 sites97 target enrollmentOctober 8, 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
etherlands Institute for Neuroscience (Netherlands)
Enrollment
97
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 8, 2009
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
etherlands Institute for Neuroscience (Netherlands)

Eligibility Criteria

Inclusion Criteria

  • 1\. For experimental group:
  • 1\.1\. Patients between 50 and 80 years of age
  • 1\.2\. Clinical diagnosis of probable (presenile) Alzheimer's Disease (AD), Mild Cognitive Impairment (MCI) or Subjective Memory Complaints provided by a neurologist or gerontologist; AD according to the Diagnosis Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM\-IV) or the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS\-ADRDA) criteria and MCI following the MCI\-standard set by Petersen (Petersen RC, et al: Neurology 2001, 56(9\):1133\-1142\).
  • 1\.3\. Mini Mental State Exam (MMSE) score \>\=14
  • 2\. For healthy control group:
  • 2\.1\. Healthy controls (age 50\-80 years)
  • 2\.2\. Free of any clinical diagnosis of dementia
  • 2\.3\. Those without subjective memory complaints
  • 2\.4\. MMSE score \=28

Exclusion Criteria

  • Patients nor healthy controls are admitted to the study if any of the following are diagnosed:
  • 1\. Any other neurological disorder, including narcolepsy
  • 2\. Any psychiatric disorder, with the exception of mild depressive symptoms
  • 3\. Serious problems with activities of daily living (ADL)
  • 4\. Sleep apnoea or restless legs syndrome
  • 5\. A serious eye disease incompatible with light therapy, such as aphakia or retinitis pigmentosa

Outcomes

Primary Outcomes

Not specified

Similar Trials